Supplements
curcumin improves depression symptoms
In plain terms: Can turmeric help with depression?
Part of: 🧪 turmeric & curcumin
Maybe, as an add-on to antidepressants. A couple of meta-analyses show a benefit, but the trials are small, overlapping, and prone to publication bias — promising, not established.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
A couple of meta-analyses find curcumin reduces depressive symptoms — but the underlying trials are small, short, heavily overlapping, mostly tested it as an add-on to antidepressants, and carry a real risk of publication bias. Promising as an adjunct, not an established antidepressant.
The evidence (12)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| She RF et al 2026 · study_type: animal | animal | supports | low | Rotenone-induced Parkinson's rat model (n=14/group); intranasal curcumin (2.5-10 mg/kg/d) reduced anxio-depressive-like behaviors (FST/TST/open field) vs vehicle, comparable to fluoxetine, via NF-κB/NLRP3 pathway modulation. |
| Kukushkina A et al 2026 · study_type: RCT | RCT | tested-null | low | 60 MS patients on IFN-β randomized to add-on micellar curcumin vs IFN-β alone for 6 months; reported 'a positive effect on depression (p=0.05)' alongside relapse-rate benefits, but this was a secondary/exploratory endpoint in a small pilot, |
| Osei-Bonsu GA et al 2026 · study_type: observational | observational | supports | low | Open-label, uncontrolled pilot trial (n=6 youth) of adjunctive curcumin (up to 1000mg BID) for treatment-resistant bipolar depression over 8 weeks; significant reduction in CGI depression/illness severity, with reduction in CDRS-R scores co |
| Sarris 2022 · World J Biol Psychiatry | observational | mixed | low | Clinician nutraceutical guidelines: curcumin has preliminary/adjunctive evidence in depression, not first-line. |
| Singh A et al 2026 · study_type: observational | observational | supports | low | Narrative review of curcumin's neuroinflammatory mechanisms in depression (NLRP3 inhibition, kynurenine pathway, inflammatory marker reduction); asserts 'evidence from clinical trials and meta-analyses suggests curcumin can significantly al |
| Zhang K et al 2025 · study_type: animal | animal | supports | low | Chronic corticosterone-induced depression/anxiety model in mice; curcumin treatment ameliorated depressive/anxiety-like behaviors and oxidative stress/neuroinflammation via p53-DDIT4-NF-κB pathway (mechanistic pharmacological rescue/challen |
| Ng 2017 · J Am Med Dir Assoc | meta-analysis | supports | low | Meta-analysis: curcumin showed clinically significant antidepressant efficacy vs placebo. |
| Yuan J et al 2025 · study_type: meta-analysis | meta-analysis | supports | moderate | Systematic review/meta-analysis of 15 RCTs (n=1123 adults) with chronic diseases; curcumin significantly reduced depressive symptoms (SMD -0.65, 95% CI -1.16 to -0.13, I²=93%) and anxiety (SMD -0.22), but authors flag considerable heterogen |
| Fusar-Poli 2020 · Crit Rev Food Sci Nutr | meta-analysis | supports | low | Meta-analysis: curcumin significantly reduced depressive symptoms across randomized trials. |
| Chen T et al 2026 · study_type: animal | animal | supports | low | In vitro (BV2 cells) and in vivo CUMS mouse model; curcumin-loaded lipid nanoparticles (CNP) alleviated depressive-like behaviors more effectively than free curcumin, with enhanced anti-inflammatory/antioxidant effects. |
| Wang 2021 · J Affect Disord | meta-analysis | mixed | moderate | SR+meta-analysis: antidepressant signal present but evidence limited by small, heterogeneous, potentially biased trials. |
| Baune BT et al 2026 · study_type: meta-analysis | meta-analysis | supports | low | Node-resolved systematic review/meta-analysis of Ayurvedic herbal products (49 controlled human reports, 20 nodes); meta-analysis was feasible for curcumin vs placebo on depression severity as one of three primary strata, showing a 'potenti |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.